UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 182

Sortiert nach

Biomarker Discovery in Non―Small Cell Lung Cancer: Integrating Gene Expression Profiling, Meta-analysis, and Tissue Microarray Validation

Clinical cancer research, 2013, Vol.19 (1), p.194-204

2013

Volltextzugriff (PDF)

Early-Stage NSCLC: Advances in Thoracic Oncology 2018

Journal of thoracic oncology, 2019-06, Vol.14 (6), p.968-978

2019

Volltextzugriff (PDF)

Exosomal RNA-profiling of pleural effusions identifies adenocarcinoma patients through elevated miR-200 and LCN2 expression

Lung cancer (Amsterdam, Netherlands), 2018-10, Vol.124, p.45-52

2018

Volltextzugriff (PDF)

Integrative analysis of genome-wide gene copy number changes and gene expression in non-small cell lung cancer

PloS one, 2017-11, Vol.12 (11), p.e0187246-e0187246

2017

Volltextzugriff (PDF)

Lung cancer prediction using machine learning on data from a symptom e-questionnaire for never smokers, formers smokers and current smokers

PloS one, 2022-10, Vol.17 (10), p.e0276703-e0276703

2022

Volltextzugriff (PDF)

Correction: Effect of body tissue composition on the outcome of patients with metastatic non-small cell lung cancer treated with PD-1/PD-L1 inhibitors

PloS one, 2023-11, Vol.18 (11), p.e0294384-e0294384

2023

Volltextzugriff (PDF)

Aberrantly activated claudin 6 and 18.2 as potential therapy targets in non‐small‐cell lung cancer

International journal of cancer, 2014-11, Vol.135 (9), p.2206-2214

2014

Volltextzugriff (PDF)

Effect of body tissue composition on the outcome of patients with metastatic non-small cell lung cancer treated with PD-1/PD-L1 inhibitors

PloS one, 2023-02, Vol.18 (2), p.e0277708-e0277708

2023

Volltextzugriff (PDF)

Matched Analyses of Brain Metastases versus Primary Non-Small Cell Lung Cancer Reveal a Unique microRNA Signature

International journal of molecular sciences, 2023-01, Vol.24 (1), p.193

2023

Volltextzugriff (PDF)

HDAC7 promotes NSCLC proliferation and metastasis via stabilization by deubiquitinase USP10 and activation of β-catenin-FGF18 pathway

Journal of experimental & clinical cancer research, 2022-03, Vol.41 (1), p.91-91, Article 91

2022

Volltextzugriff (PDF)

The mTOR Pathway in Lung Cancer and Implications for Therapy and Biomarker Analysis

Journal of thoracic oncology, 2012-06, Vol.7 (6), p.947-953

2012

Volltextzugriff (PDF)

Outcome of Patients with NSCLC and Brain Metastases Treated with Immune Checkpoint Inhibitors in a 'Real-Life' Setting

Cancers, 2020-12, Vol.12 (12), p.3707

2020

Volltextzugriff (PDF)

Correlation of Clinical Parameters with Intracranial Outcome in Non-Small Cell Lung Cancer Patients with Brain Metastases Treated with Pd-1/Pd-L1 Inhibitors as Monotherapy

Cancers, 2021-03, Vol.13 (7), p.1562

2021

Volltextzugriff (PDF)

Multiplex immune protein profiling of fine‐needle aspirates from patients with non‐small‐cell lung cancer reveals signatures associated with PD‐L1 expression and tumor stage

Molecular oncology, 2021-11, Vol.15 (11), p.2941-2957

2021

Volltextzugriff (PDF)

Ras-Related Protein Rab-32 and Thrombospondin 1 Confer Resistance to the EGFR Tyrosine Kinase Inhibitor Osimertinib by Activating Focal Adhesion Kinase in Non-Small Cell Lung Cancer

Cancers, 2022-07, Vol.14 (14), p.3430

2022

Volltextzugriff (PDF)

CD99 is a novel prognostic stromal marker in non-small cell lung cancer

International journal of cancer, 2012-11, Vol.131 (10), p.2264-2273

2012

Volltextzugriff (PDF)

ALK-Brain Prognostic Index—Preliminary Study of a Prognostic Tool for Patients with ALK-Rearranged, Non-small Cell Lung Cancer and Brain Metastases

Cancers, 2020-07, Vol.12 (7), p.1804

2020

Volltextzugriff (PDF)

Brain exposure of osimertinib in patients with epidermal growth factor receptor mutation non‐small cell lung cancer and brain metastases: A positron emission tomography and magnetic resonance imaging study

Clinical and translational science, 2023-06, Vol.16 (6), p.955-965

2023

Volltextzugriff (PDF)

Characterizing single extracellular vesicles by droplet barcode sequencing for protein analysis

Journal of extracellular vesicles, 2022-11, Vol.11 (11), p.e12277-n/a

2022

Volltextzugriff (PDF)

Detection of Tumor-Associated Membrane Receptors on Extracellular Vesicles from Non-Small Cell Lung Cancer Patients via Immuno-PCR

Cancers, 2021-02, Vol.13 (4), p.922

2021

Volltextzugriff (PDF)

Synergistic effects of combining proteasome inhibitors with chemotherapeutic drugs in lung cancer cells

BMC research notes, 2017-11, Vol.10 (1), p.544-544, Article 544

2017

Volltextzugriff (PDF)

A study of embryonic stem cell‐related proteins in human astrocytomas: Identification of Nanog as a predictor of survival

International journal of cancer, 2014-03, Vol.134 (5), p.1123-1131

2014

Volltextzugriff (PDF)

Human cytomegalovirus tegument protein pp65 is detected in all intra- and extra-axial brain tumours independent of the tumour type or grade

PloS one, 2014-09, Vol.9 (9), p.e108861-e108861

2014

Volltextzugriff (PDF)

Synthesis, Characterization, and Adsorption Properties of Nitrogen-Doped Nanoporous Biochar: Efficient Removal of Reactive Orange 16 Dye and Colorful Effluents

Nanomaterials (Basel, Switzerland), 2023-07, Vol.13 (14), p.2045

2023

Volltextzugriff (PDF)

Cancer Cachexia and Antitumor Immunity: Common Mediators and Potential Targets for New Therapies

Life (Basel, Switzerland), 2022-06, Vol.12 (6), p.880

2022

Volltextzugriff (PDF)

1 – 25 von 182

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(168)
Mit Volltextzugriff
(173)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Biomarker Discovery in Non―Small Cell Lung Cancer: Integrating Gene Expression Profiling, Meta-analysis, and Tissue Microarray Validation

Early-Stage NSCLC: Advances in Thoracic Oncology 2018

Exosomal RNA-profiling of pleural effusions identifies adenocarcinoma patients through elevated miR-200 and LCN2 expression

Integrative analysis of genome-wide gene copy number changes and gene expression in non-small cell lung cancer

Lung cancer prediction using machine learning on data from a symptom e-questionnaire for never smokers, formers smokers and current smokers

Correction: Effect of body tissue composition on the outcome of patients with metastatic non-small cell lung cancer treated with PD-1/PD-L1 inhibitors

Aberrantly activated claudin 6 and 18.2 as potential therapy targets in non‐small‐cell lung cancer

Effect of body tissue composition on the outcome of patients with metastatic non-small cell lung cancer treated with PD-1/PD-L1 inhibitors

Matched Analyses of Brain Metastases versus Primary Non-Small Cell Lung Cancer Reveal a Unique microRNA Signature

HDAC7 promotes NSCLC proliferation and metastasis via stabilization by deubiquitinase USP10 and activation of β-catenin-FGF18 pathway

The mTOR Pathway in Lung Cancer and Implications for Therapy and Biomarker Analysis

Outcome of Patients with NSCLC and Brain Metastases Treated with Immune Checkpoint Inhibitors in a 'Real-Life' Setting

Correlation of Clinical Parameters with Intracranial Outcome in Non-Small Cell Lung Cancer Patients with Brain Metastases Treated with Pd-1/Pd-L1 Inhibitors as Monotherapy

Multiplex immune protein profiling of fine‐needle aspirates from patients with non‐small‐cell lung cancer reveals signatures associated with PD‐L1 expression and tumor stage

Ras-Related Protein Rab-32 and Thrombospondin 1 Confer Resistance to the EGFR Tyrosine Kinase Inhibitor Osimertinib by Activating Focal Adhesion Kinase in Non-Small Cell Lung Cancer

CD99 is a novel prognostic stromal marker in non-small cell lung cancer

ALK-Brain Prognostic Index—Preliminary Study of a Prognostic Tool for Patients with ALK-Rearranged, Non-small Cell Lung Cancer and Brain Metastases

Brain exposure of osimertinib in patients with epidermal growth factor receptor mutation non‐small cell lung cancer and brain metastases: A positron emission tomography and magnetic resonance imaging study

Characterizing single extracellular vesicles by droplet barcode sequencing for protein analysis

Detection of Tumor-Associated Membrane Receptors on Extracellular Vesicles from Non-Small Cell Lung Cancer Patients via Immuno-PCR

Synergistic effects of combining proteasome inhibitors with chemotherapeutic drugs in lung cancer cells

A study of embryonic stem cell‐related proteins in human astrocytomas: Identification of Nanog as a predictor of survival

Human cytomegalovirus tegument protein pp65 is detected in all intra- and extra-axial brain tumours independent of the tumour type or grade

Synthesis, Characterization, and Adsorption Properties of Nitrogen-Doped Nanoporous Biochar: Efficient Removal of Reactive Orange 16 Dye and Colorful Effluents

Cancer Cachexia and Antitumor Immunity: Common Mediators and Potential Targets for New Therapies

Suchergebnisse filtern